News | Archive | 2012

Osprey Medical Inc. announces enrolment of first patient in Diabetic Limb Clinical Study
Posted: 2012-12-04 in Press Releases

Osprey Medical Inc. enhances CINCOR™ with addition of new proprietary dye reduction system
Posted: 2012-11-19 in Press Releases

Janssen Industry Excellence Awards announced at AusBiotech 2012
Posted: 2012-11-01 in Press Releases

Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines
Posted: 2012-10-17 in Press Releases

Brandon Capital Partners receives AVCAL Excellence in Investor Reporting Award 2012
Posted: 2012-09-20 in Press Releases

Spinifex Pharmaceuticals releases positive Phase 2 Results for EMA401 in Postherpetic Neuralgia
Posted: 2012-08-28 in Press Releases

Osprey Medical Inc. receives A$1.1 million Victorian Government Grant
Posted: 2012-07-04 in Press Releases

Osprey Medical appoints Mr Neville Mitchell to its Board of Directors
Posted: 2012-07-03 in Press Releases

Investment in Vaxxas winner at 2012 Vaccine Industry Awards
Posted: 2012-04-17 in Press Releases

Fibrotech announces positive preclinical proof of concept
Posted: 2012-03-01 in Press Releases

Vaxxas makes BRW's Top 10 Start-Ups 2011
Posted: 2012-02-09 in Press Releases